Stay updated on Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.

Latest updates to the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page
- Check5 days agoChange Detected- Revision label updated from v3.4.2 to v3.4.3 in the page footer. - No impact on study data or user workflow.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision label, v3.4.2, was added to the history. The deleted notices include a government funding status notice and the older v3.4.1 entry, reflecting administrative updates to the page's version history.SummaryDifference0.7%

- Check41 days agoChange DetectedAdded a general site status notice about government funding lapse and the NIH Clinical Center's status. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.7%

- Check48 days agoChange DetectedThe history view now includes a glossary toggle and color-coded diffs (green for additions, red for deletions) with explicit revision notes (e.g., Revision: v3.4.0) to improve clarity of changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check62 days agoChange DetectedMinor site revision update from v3.3.3 to v3.3.4; it does not alter study data or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedA new revision entry v3.3.3 was added to the record history and references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

Stay in the know with updates to Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.